Integra LifeSciences Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Integra LifeSciences (IART) Misses Q1 EPS by 16c
May 7, 2020 6:41 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q1 EPS of $0.48, $0.16 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $354.3 million versus the consensus estimate of $363.24 million.
2020 Full-Year Outlook
Given the existing uncertainty related to COVID-19, the Companys guidance for the full-year 2020, issued... More



